Understanding how immune cells in the eye affect fat balance and inflammation in age-related macular degeneration.
Role of choroidal macrophages in regulating lipid homeostasis and immunosuppression of the RPE/choroid
This study is looking at how certain immune cells in the eye help keep things balanced and reduce inflammation in people with age-related macular degeneration (AMD), with the hope of finding new ways to treat the dry form of this condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10917181 on NIH RePORTER |
What this research studies
This research investigates the role of choroidal macrophages, a type of immune cell in the eye, in maintaining lipid balance and controlling inflammation in age-related macular degeneration (AMD). By analyzing RNA-sequencing data from human donors, the study aims to uncover how these macrophages function and their impact on the retinal pigmented epithelium (RPE) and choroid. The research seeks to identify the molecular mechanisms that lead to lipid accumulation and inflammation, which are critical factors in the progression of AMD. This could provide insights into potential therapeutic targets for treating AMD, particularly its dry form, which currently lacks FDA-approved treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with age-related macular degeneration, particularly those with the dry subtype.
Not a fit: Patients with other forms of macular degeneration or those without any retinal conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing age-related macular degeneration, potentially improving vision and quality of life for patients.
How similar studies have performed: Other research has shown promise in understanding the role of immune cells in retinal diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Fortmann, Seth D — University of Alabama at Birmingham
- Study coordinator: Fortmann, Seth D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.